RENSSELAER, N.Y., Nov 5 (Bernama-GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, expands its robust neurodegeneration portfolio with the launch of a new Alzheimer’s disease model, the ARTE10 mouse model.
Exclusively available from Taconic, the ARTE10 is a transgenic mouse model expressing mutant human APP and PS1 genes. This combination manifests in early onset of amyloid plaques, with downstream cognitive deficits commonly associated with Alzheimer’s disease. The plaques formed in the ARTE10 model are particularly suitable for PET imaging, making ARTE10 valuable for translational research.